GL1X · GenesisL1 explorer

Research workbench

Leishmania major tyrosyl-tRNA synthetase in complex with tyrosinol, cubic crystal form

Analyse Leishmania major tyrosyl-tRNA synthetase in complex with tyrosinol, cubic… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3P0I
Type
protein
Length
1,209 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosyl-tRNA synthetase
EC
6.1.1.1
UniProt
Q4QFJ7
Ligands
TYE
Pockets
12 · best druggability 0.76

Structure

x-ray diffraction · 2 distinct chains · 51% helix, 11% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosyl-tRNA synthetase (EC 6.1.1.1)protein67351% helix, 10% strandQ4QFJ7
BTyrosyl-tRNA synthetase (EC 6.1.1.1)protein53652% helix, 11% strandQ4QFJ7

Ligands and binding sites

  • TYE · 4-[(2S)-2-amino-3-hydroxypropyl]phenol · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

12 pockets found on a 1 Å grid, 8 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16760.760.8274TYE
25440.760.8359TYE
37860.690.7684empty
46000.660.7661empty
51080.520.8322empty

Interfaces

1 interface between chains.

  • A–B · 1068 Ų buried · 9 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 37 modified (engineered).

Compared structures

  • 3P0I · Leishmania major Tyrosyl-tRNA synthetase in complex with tyrosinol, cubic crystal form · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.